Oral sulfonylureas (like glimepiride, glyburide, and tolazamide) trigger the pancreas to make more insulin.
Review Date: 5/22/2007 Reviewed By: A.D.A.M. Editorial Team: Greg Juhn, MTPW, David R. Eltz. Previously reviewed by Nikheel S. Kolatkar, MD, Clinical and Research Fellow, Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. Review provided by VeriMed Healthcare Network. (1/23/2006)